NASDAQ
Crescent Biopharma, Inc. (CBIO) has a current ratio of 6.56x as of Monday, May 25, 2026. This represents a 12.07% increase compared to its 12-month average of 5.85x. The current ratio measures a company's ability to cover short-term obligations by comparing current assets to current liabilities.
No price data available for this timeframe.